论文部分内容阅读
目的观察冠心病心绞痛常规治疗与常规治疗基础上加用马来酸桂哌齐特治疗冠心病心绞痛的临床疗效。方法选择符合冠心病心绞痛诊断标准的病例共42例,随机分为对照组22例,治疗组20例,对照组采用冠心病常规治疗,即抗血小板,抗凝,扩冠,活血治疗。治疗组加用马来酸桂哌齐特160mg,静脉滴注,每日一次,治疗2周。结果治疗组与对照组比较,心绞痛与心电图改善情况有显著性差异,没有明显的不良反应,安全性好。结论马来酸桂哌齐特联合治疗冠心病心绞痛疗效显著,安全可靠。
Objective To observe the clinical effects of conventional therapy and conventional therapy on angina pectoris of coronary heart disease treated with cinepazide maleate in the treatment of angina pectoris. Methods Forty-two patients with coronary heart disease diagnosed as angina pectoris were randomly divided into control group (n = 22) and treatment group (n = 20). Patients in the control group were treated with anti-platelet, anticoagulation, The treatment group plus cinepazide maleate 160mg, intravenously, once daily for 2 weeks. Results Compared with the control group, there was a significant difference in the improvement of angina pectoris and electrocardiogram between the treatment group and the control group, with no obvious adverse reactions and good safety. Conclusion The combination of cinepazide maleate in the treatment of angina pectoris has significant curative effect and is safe and reliable.